Coscia et al. (154) compared proteome of FFPE tumor samples from chemoresistant and chemosensitive HGSOC patients, and identified cancer/testis antigen 45 (CT45) as a favorable prognosis biomarker. This evidence concerns the gene CT45A1 and neoplasm.